---
figid: PMC3195922__bph0164-1008-f14
figlink: /pmc/articles/PMC3195922/figure/fig14/
number: Figure 14
caption: Proposed signalling mechanism for the effects of kaempferol on LPS-induced
  neuroinflammation in BV2 cells. Activation of toll-like receptor-4 (TLR4) with LPS
  leads to activation of IKK complex, and MAPKs and AKT pathways. The IKK complex
  phosphorylates IκB, which leads to the degradation of IκBα and the subsequent nuclear
  translocation of NF-κB. Similarly, p38 MAPK and JNK phosphorylate and activate AP-1.
  Phosphorylation of AKT also leads to activation of NF-κB. Activation of NF-κB and
  AP-1 results in the expression and production of pro-inflammatory mediators. Kaempferol
  disrupts the neurotoxic pathway and protects against LPS-induced toxicity through
  inhibition of NF-κB, MAPKs and AKT signalling. IKK, inhibitor of nuclear factor-κB
  (IκB)-kinase; Kae, kaempferol.
pmcid: PMC3195922
papertitle: Kaempferol acts through mitogen-activated protein kinases and protein
  kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial
  cells.
reftext: SE Park, et al. Br J Pharmacol. 2011 Oct;164(3):1008-1025.
pmc_ranked_result_index: '50484'
pathway_score: 0.9674507
filename: bph0164-1008-f14.jpg
figtitle: Proposed signalling mechanism for the effects of kaempferol on LPS-induced
  neuroinflammation in BV2 cells
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3195922__bph0164-1008-f14.html
  '@type': Dataset
  description: Proposed signalling mechanism for the effects of kaempferol on LPS-induced
    neuroinflammation in BV2 cells. Activation of toll-like receptor-4 (TLR4) with
    LPS leads to activation of IKK complex, and MAPKs and AKT pathways. The IKK complex
    phosphorylates IκB, which leads to the degradation of IκBα and the subsequent
    nuclear translocation of NF-κB. Similarly, p38 MAPK and JNK phosphorylate and
    activate AP-1. Phosphorylation of AKT also leads to activation of NF-κB. Activation
    of NF-κB and AP-1 results in the expression and production of pro-inflammatory
    mediators. Kaempferol disrupts the neurotoxic pathway and protects against LPS-induced
    toxicity through inhibition of NF-κB, MAPKs and AKT signalling. IKK, inhibitor
    of nuclear factor-κB (IκB)-kinase; Kae, kaempferol.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - MAPK8
  - AKT3
  - IKBKB
  - IKBKG
  - MAPK9
  - MAPK12
  - NFKBIA
  - MAPK11
  - MAPK13
  - IRF6
  - CHUK
  - MAPK10
  - AKT1
  - JUND
  - FOSL2
  - MAPK14
  - JUN
  - JUNB
  - TNF
  - FOSL1
  - NFKB1
  - FOS
  - FOSB
  - AKT2
  - MMP3
  - PGE2
genes:
- word: IL-1B,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MMP-3
  symbol: MMP3
  source: hgnc_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
---
